SCHEMBL9414402

SCHEMBL9414402

Cc1cc2cc(CCBr)ccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.53
▸ ALDH1A1 P00352 5/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ LMNA P02545 2/20 0.50
▸ CYP2A6 P11509 1/20 0.50
▸ KEAP1 Q14145 1/20 0.50
▸ HPGD P15428 3/20 0.49
▸ HTT P42858 3/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ AXL P30530 1/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ PABPC1 P11940 1/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23278441 0.84 MAPT (0.57) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL9276363 0.82 MAPT (0.56) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL8999779 0.79 MAPT (0.57) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL11374192 0.79 AXL (0.53) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL20391674 0.79 MAPT (0.50) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL29673249 0.78 CYP2A6 (0.58) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL12452461 0.78 MAPT (0.59) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL6683148 0.78 CYP2A6 (0.58) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL14629866 0.78 MAPT (0.55) MAPTALDH1A1KDM4ELMNACYP2A6
SCHEMBL28762518 0.77 AXL (0.50) MAPTALDH1A1KDM4ELMNACYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0628821-A2 Device for validating urobilinogen test devices Bayer Corporation (US) 1994-12-14 — — EP disclosed
Send feedback